Related Experiment Video
Updated: Jun 27, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Severe sepsis in a premature neonate: protein C replacement therapy
Maria Pia De Carolis1, Valentina Polimeni, Patrizia Papacci
1Division of Neonatal Intensive Care, Department of Pediatrics, Catholic University of Sacred Heart, Rome, Italy.
Abstract:
Treatment with activated protein C has been shown to reduce mortality in adult patients with severe sepsis but also to increase risk of bleeding. In patients with predisposition to bleeding, as in preterm infants, the inactivated form of protein C could serve as a safe therapeutic option. We report the case of a preterm neonate who developed severe sepsis on the 28th day of life, who was successfully treated with the inactivated form of protein C for a period of 96 hours.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pyelonephritis II: Diagnostic Studies and Management

